- Report
- February 2026
- 471 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 580 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 205 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 480 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 222 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 193 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 194 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 263 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 212 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 183 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 273 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 215 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 220 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 181 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 260 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 279 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 179 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 196 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 194 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 192 Pages
Global
From €5124EUR$5,850USD£4,447GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more